Increased p38 and JNK phosphorylation has previously been described in animal models of glaucoma [18–21] and p38 or JNK pathway inhibition has been shown to protect RGCs following axotomy [22, 23] and ischemia [18]. This evidence concerns the gene MAPK8 and glaucoma.